In contrast to MFI, the frequency of BDCA-2+ pDCs is not influenced by HIV-1 infection, and in vitro activation of pDC via TLR7/9 agonists leads to downregulation of the pDC surface-localized BDCA-2 [14]. Here, CLEC4C is linked to HIV-1 infection.